Free Trial
NYSE:ALC

Alcon (ALC) Stock Price, News & Analysis

Alcon logo
$79.82 +0.38 (+0.47%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$79.48 -0.33 (-0.41%)
As of 08/29/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alcon Stock (NYSE:ALC)

Key Stats

Today's Range
$79.32
$80.28
50-Day Range
$79.16
$92.25
52-Week Range
$78.11
$101.10
Volume
1.96 million shs
Average Volume
2.56 million shs
Market Capitalization
$39.37 billion
P/E Ratio
37.12
Dividend Yield
N/A
Price Target
$96.06
Consensus Rating
Moderate Buy

Company Overview

Alcon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

ALC MarketRank™: 

Alcon scored higher than 63% of companies evaluated by MarketBeat, and ranked 330th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alcon has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on 9 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Alcon has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Alcon's stock forecast and price target.
  • Earnings Growth

    Earnings for Alcon are expected to grow by 8.58% in the coming year, from $3.03 to $3.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alcon is 37.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 270.87.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alcon is 37.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.51.

  • Price to Earnings Growth Ratio

    Alcon has a PEG Ratio of 2.52. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Alcon has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Alcon's valuation and earnings.
  • Percentage of Shares Shorted

    1.44% of the float of Alcon has been sold short.
  • Short Interest Ratio / Days to Cover

    Alcon has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Alcon has recently increased by 2.18%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Alcon does not currently pay a dividend.

  • Dividend Growth

    Alcon has only been increasing its dividend for 4 years.

  • Dividend Sustainability

    Based on earnings estimates, Alcon will have a dividend payout ratio of 10.03% next year. This indicates that Alcon will be able to sustain or increase its dividend.

  • Percentage of Shares Shorted

    1.44% of the float of Alcon has been sold short.
  • Short Interest Ratio / Days to Cover

    Alcon has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Alcon has recently increased by 2.18%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Alcon has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.11 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Alcon this week, compared to 6 articles on an average week.
  • Search Interest

    8 people have searched for ALC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Alcon to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alcon insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    53.86% of the stock of Alcon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alcon's insider trading history.
Receive ALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALC Stock News Headlines

Solid Earnings May Not Tell The Whole Story For Alcon (VTX:ALC)
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
RBC Capital Remains a Buy on Alcon (ALC)
UBS Keeps Their Buy Rating on Alcon (ALC)
Alcon’s UNITY VCS Lays Foundation for Next-Gen Cataract & Retinal Surgery
Alcon to Present at 2025 Baird Global Healthcare Conference
See More Headlines

ALC Stock Analysis - Frequently Asked Questions

Alcon's stock was trading at $84.89 on January 1st, 2025. Since then, ALC shares have decreased by 6.0% and is now trading at $79.8160.

Alcon (NYSE:ALC) released its earnings results on Tuesday, August, 19th. The healthcare company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.05. Alcon's revenue for the quarter was up 3.8% on a year-over-year basis.
Read the conference call transcript
.

Alcon's Board of Directors approved a stock buyback plan on Tuesday, February 25th 2025, which permits the company to buy back $750,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 1.7% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Alcon subsidiaries include Alcon (China) Ophthalmic Product Co. Ltd., Alcon Finance Corporation, Alcon Japan Ltd., Alcon Laboratories Inc., Alcon Pharmaceuticals Ltd., Alcon Research LLC, and Alcon Vision LLC.

Top institutional shareholders of Alcon include Vanguard Group Inc. (4.23%), Norges Bank (2.30%), Bank of New York Mellon Corp (1.98%) and Select Equity Group L.P. (1.37%).

Shares of ALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alcon investors own include CocaCola (KO), AT&T (T), Walt Disney (DIS), PepsiCo (PEP), Verizon Communications (VZ), Cisco Systems (CSCO) and Johnson & Johnson (JNJ).

Company Calendar

Last Earnings
8/19/2025
Today
9/01/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:ALC
CIK
1167379
Employees
25,599
Year Founded
1945

Price Target and Rating

High Price Target
$112.00
Low Price Target
$77.53
Potential Upside/Downside
+20.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.15
Trailing P/E Ratio
37.12
Forward P/E Ratio
26.34
P/E Growth
2.52
Net Income
$1.02 billion
Net Margins
10.70%
Pretax Margin
12.51%
Return on Equity
6.92%
Return on Assets
4.89%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
2.60
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$9.91 billion
Price / Sales
3.97
Cash Flow
$5.56 per share
Price / Cash Flow
14.36
Book Value
$43.70 per share
Price / Book
1.83

Miscellaneous

Outstanding Shares
493,240,000
Free Float
N/A
Market Cap
$39.37 billion
Optionable
Optionable
Beta
0.99

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:ALC) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners